Clinical Trials Browser

Infectious Mononucleosis × Clear all

NCT05683834 2026-04-22

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Phase 1/2 Completed

Herpes Simplex, Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00032513 2026-04-08

Genetic Studies of Chronic Active Epstein-Barr Disease

Herpes Simplex, Infectious Mononucleosis, Lymphoproliferative Disorders, Virus Diseases, Epstein-Barr Virus Infections

NCT06908096 2026-03-30

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Phase 1 Recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05831111 2025-09-30

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

Phase 1 Active not recruiting

Infections, Infectious Mononucleosis, Virus Diseases, Epstein-Barr Virus Infections

NCT04645147 2025-07-17

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Phase 1 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05164094 2025-05-15

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Phase 1/2 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05127980 2025-02-25

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

Infections, Infectious Mononucleosis, Lupus Erythematosus, Systemic, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

NCT06002802 2024-02-07

IMMUC

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT03546101 2023-10-31

Early Detection of Epstein-Barr Virus Related Disease.

Infectious Mononucleosis, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT06005246 2023-08-22

MUC-CFS

Post-Acute COVID-19 Syndrome, Infectious Mononucleosis, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

NCT05473325 2022-08-15

BRANCH-P

OtherOther hematologic neoplasm

Acquired Immunodeficiency Syndrome, Alzheimer Disease, Appendicitis, Arthritis, Bronchitis, Bulimia, Cardiovascular Diseases, Cellulitis, Depression, Diabetes Mellitus, Dyspepsia, Eczema, Fibrosis, Gout, Heart Diseases, Hypercholesterolemia, Hypersensitivity, Infections, Infectious Mononucleosis, Influenza, Human, Intestinal Diseases, Leukemia, Liver Diseases, Alcoholic, Neoplasms, Obesity, Osteoporosis, HIV Infections, Renal Insufficiency, Chronic

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Phase 2 Withdrawn

Other hematologic neoplasm

Infectious Mononucleosis, Hematologic Neoplasms

NCT05225493 2022-02-04

#AwareHIV

Classical hematologyGynecologic

Lymphadenopathy, Acquired Immunodeficiency Syndrome, Candidiasis, Uterine Cervical Dysplasia, Herpes Zoster, Infectious Mononucleosis, Leukopenia, Pneumonia, Psoriasis, Dermatitis, Seborrheic, Thrombocytopenia, Sexually Transmitted Diseases, Viral, Weight Loss, HIV Infections

NCT03650231 2018-08-28

DIAGEPS

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00359411 2017-07-02

Genetic Studies of X-linked Lymphoproliferative Disease

Infectious Mononucleosis, Lymphoproliferative Disorders, Lymphoma, B-Cell, Epstein-Barr Virus Infections, Genetic Diseases, X-Linked

NCT00575185 2017-03-22

Mono6

Phase 1/2 Completed

23 enrolled 8 charts

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Phase 1/2 Completed

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT00430534 2007-02-02

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Phase 2 Completed

Infections, Infectious Mononucleosis, Epstein-Barr Virus Infections